KR100944052B1 - 하이퍼포린 유도체, 그의 용도 및 그를 함유한 제제 - Google Patents

하이퍼포린 유도체, 그의 용도 및 그를 함유한 제제 Download PDF

Info

Publication number
KR100944052B1
KR100944052B1 KR1020047016491A KR20047016491A KR100944052B1 KR 100944052 B1 KR100944052 B1 KR 100944052B1 KR 1020047016491 A KR1020047016491 A KR 1020047016491A KR 20047016491 A KR20047016491 A KR 20047016491A KR 100944052 B1 KR100944052 B1 KR 100944052B1
Authority
KR
South Korea
Prior art keywords
methyl
derivative
hyperporin
positions
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020047016491A
Other languages
English (en)
Korean (ko)
Other versions
KR20040111519A (ko
Inventor
에지오 봄바르델리
파올로 모라쪼니
안토넬라 리바
니콜라 후자티
Original Assignee
인데나 에스피아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 인데나 에스피아 filed Critical 인데나 에스피아
Publication of KR20040111519A publication Critical patent/KR20040111519A/ko
Application granted granted Critical
Publication of KR100944052B1 publication Critical patent/KR100944052B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C07C49/733—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/46—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing nine carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Semiconductor Lasers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020047016491A 2002-04-23 2003-04-18 하이퍼포린 유도체, 그의 용도 및 그를 함유한 제제 Expired - Fee Related KR100944052B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2002MI000872A ITMI20020872A1 (it) 2002-04-23 2002-04-23 Derivati dell'iperforina loro uso e formulazioni che li contengono
ITMI2002A000872 2002-04-23
PCT/EP2003/004100 WO2003091194A1 (en) 2002-04-23 2003-04-18 Hyperforin derivatives, the use thereof and formulations containing them

Publications (2)

Publication Number Publication Date
KR20040111519A KR20040111519A (ko) 2004-12-31
KR100944052B1 true KR100944052B1 (ko) 2010-02-24

Family

ID=11449767

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047016491A Expired - Fee Related KR100944052B1 (ko) 2002-04-23 2003-04-18 하이퍼포린 유도체, 그의 용도 및 그를 함유한 제제

Country Status (18)

Country Link
US (2) USRE43280E1 (https=)
EP (1) EP1497250B1 (https=)
JP (1) JP4315818B2 (https=)
KR (1) KR100944052B1 (https=)
CN (1) CN1290816C (https=)
AT (1) ATE404519T1 (https=)
CA (1) CA2483205C (https=)
DE (1) DE60322871D1 (https=)
DK (1) DK1497250T3 (https=)
ES (1) ES2311697T3 (https=)
IL (1) IL164763A (https=)
IT (1) ITMI20020872A1 (https=)
NO (1) NO329176B1 (https=)
PL (1) PL205829B1 (https=)
PT (1) PT1497250E (https=)
RU (1) RU2320636C2 (https=)
SI (1) SI1497250T1 (https=)
WO (1) WO2003091194A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102772461B (zh) * 2011-05-11 2014-05-14 成都康弘药业集团股份有限公司 药物组合物在制备预防或治疗老年性痴呆的药物中的应用
US9321713B2 (en) * 2011-06-03 2016-04-26 President And Fellows Of Harvard College Hyperforin analogs, methods of synthesis, and uses thereof
ITMI20131012A1 (it) * 2013-06-19 2014-12-20 Indena Spa Derivati dell'iperforina e loro uso nella malattia di alzheimer
US20180071269A1 (en) 2015-08-12 2018-03-15 Tianxin Wang Therapeutical methods, formulations and nutraceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2162520T3 (es) * 1998-02-13 2001-12-16 Schwabe Willmar Gmbh & Co Medicamentos basados en hiperforina y/o extractos de hiperforina.
AU743956B2 (en) 1998-02-13 2002-02-07 Dr. Willmar Schwabe Gmbh & Co Stable hyperforin salts, method for producing same and their use in the treatment of Alzheimer's disease
IT1301679B1 (it) * 1998-06-10 2000-07-07 Indena Spa Derivati dell'iperforina, loro uso e formulazioni che licontengono.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
해당사항없음

Also Published As

Publication number Publication date
HK1075654A1 (en) 2005-12-23
RU2004131210A (ru) 2005-04-10
DK1497250T3 (da) 2008-12-01
AU2003222828A1 (en) 2003-11-10
ES2311697T3 (es) 2009-02-16
USRE43280E1 (en) 2012-03-27
RU2320636C2 (ru) 2008-03-27
CN1646462A (zh) 2005-07-27
ATE404519T1 (de) 2008-08-15
CN1290816C (zh) 2006-12-20
US7105705B2 (en) 2006-09-12
IL164763A (en) 2010-02-17
NO20044519L (no) 2004-11-02
CA2483205A1 (en) 2003-11-06
EP1497250A1 (en) 2005-01-19
NO329176B1 (no) 2010-09-06
CA2483205C (en) 2011-07-05
JP2005523917A (ja) 2005-08-11
WO2003091194A1 (en) 2003-11-06
DE60322871D1 (de) 2008-09-25
KR20040111519A (ko) 2004-12-31
ITMI20020872A1 (it) 2003-10-23
ITMI20020872A0 (it) 2002-04-23
JP4315818B2 (ja) 2009-08-19
US20050165117A1 (en) 2005-07-28
SI1497250T1 (sl) 2008-12-31
PL371347A1 (en) 2005-06-13
PT1497250E (pt) 2008-11-12
IL164763A0 (en) 2005-12-18
PL205829B1 (pl) 2010-05-31
EP1497250B1 (en) 2008-08-13

Similar Documents

Publication Publication Date Title
JPH04247054A (ja) カルノシン酸の製造法
CA2644570A1 (fr) Derive de resveratrol a longue chaine hydroxylee utiles comme neurotrophiques
JP2022512777A (ja) カンナビノイドの共結晶の固体組成物
Gschwend et al. Intramolecular Diels-Alder reactions. Synthesis of 3a-phenylisoindolines as analgetic templates
Wróbel Pyrrolizidine alkaloids
KR100944052B1 (ko) 하이퍼포린 유도체, 그의 용도 및 그를 함유한 제제
US20090221019A1 (en) Core-Modified Terpene Trilactones From Ginkgo Biloba Extract and Biological Evaluation Thereof
KR100627933B1 (ko) 하이퍼포린 유도체, 그의 용도 및 그를 함유한 제제
ES2736599T3 (es) Nuevos compuestos naturales antineurodegenerativos aislados a partir de Alpiniae oxyphyllae fructus y síntesis total de los mismos
AU2003222828B2 (en) Hyperforin derivatives, the use thereof and formulations containing them
KR20160026462A (ko) 피페론구민과 그 유도체 및 그 합성방법
AU2019218153B2 (en) Therapeutic drug for neurodegenerative disease and application thereof
KR20040111537A (ko) 하이퍼포린의 할로겐화된 유도체, 그의 용도 및 그를함유한 제제
CN118384154A (zh) 愈创木烷类倍半萜衍生物在制备治疗炎症性疾病的药物中的应用
Rehman et al. Incensole derivatives from frankincense: Isolation, enhancement, synthetic modification, and a plausible mechanism of their anti-depression activity
HK1075654B (en) Hyperforin derivatives, the use thereof and formulations containing them
Almazrua Synthesis of Cafestol and Ent-kaurene Derivatives
Patil Total synthesis of (±)-periconianone A and (+)-dibenzyl-banistenoside B
CN115040503A (zh) 螺环二烯酮型木脂素类化合物在制药中的应用
CN118530208A (zh) 胡椒酰胺类化合物及其应用
Lazer et al. Synthesis and biological activity of cocaine analogs. 2. 6H-[2] Benzopyrano [4, 3-c] pyridin-6-ones
KR20010037653A (ko) 베타-카르볼린유도체를 포함하는 항염증제 조성물
Bastin Synthesis of Isotopically Labeled Co-Enzyme to Probe the Active Site of Tryptophan synthase/New Synthetic Approach to Tetrahydrocannabinol Analogs
Kraus et al. APPENDIX E. THE SYNTHESIS AND NATURAL DISTRIBUTION OF THE MAJOR KETONE CONSTITUENTS IN ECHINACEA PALLIDA

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20130215

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20140203

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20150129

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20160127

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180218

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180218